| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| lapatinib | eukaryotic elongation factor 2 kinase | NA | Successful target | TTD , DGIDB | Breast[MeSHID:D001940] Neoplasms[MeSHID:D009369] Neoplasm Metastasis[MeSHID:D009362] Malignant neoplasm of breast[MeSHID:D001943] Epidermis[MeSHID:D004817] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
2.36 | approved | unknown |
| lapatinib | epidermal growth factor receptor | small molecule | Successful target | TTD , drugbank , DGIDB | Breast[MeSHID:D001940] Neoplasms[MeSHID:D009369] Neoplasm Metastasis[MeSHID:D009362] Malignant neoplasm of breast[MeSHID:D001943] Epidermis[MeSHID:D004817] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.62 | approved,investigational | antagonist |
| lapatinib | epidermal growth factor receptor | small molecule | Successful target | TTD , drugbank , DGIDB | Breast[MeSHID:D001940] Neoplasms[MeSHID:D009369] Neoplasm Metastasis[MeSHID:D009362] Malignant neoplasm of breast[MeSHID:D001943] Epidermis[MeSHID:D004817] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.62 | approved,investigational | antagonist,inhibitor |
| lapatinib | receptor tyrosine-protein kinase erbb-2 | small molecule | NA | drugbank , DGIDB | Breast[MeSHID:D001940] Neoplasms[MeSHID:D009369] Neoplasm Metastasis[MeSHID:D009362] Malignant neoplasm of breast[MeSHID:D001943] Epidermis[MeSHID:D004817] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.2 | approved,investigational | antagonist,inhibitor |
| lapatinib | receptor tyrosine-protein kinase erbb-2 | small molecule | NA | drugbank , DGIDB | Breast[MeSHID:D001940] Neoplasms[MeSHID:D009369] Neoplasm Metastasis[MeSHID:D009362] Malignant neoplasm of breast[MeSHID:D001943] Epidermis[MeSHID:D004817] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.2 | approved,investigational | antagonist |
| lapatinib | erbb2 tyrosine kinase receptor | NA | Successful target | TTD , DGIDB | Breast[MeSHID:D001940] Neoplasms[MeSHID:D009369] Neoplasm Metastasis[MeSHID:D009362] Malignant neoplasm of breast[MeSHID:D001943] Epidermis[MeSHID:D004817] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.2 | approved | inhibitor |
| lapatinib | erbb2 tyrosine kinase receptor | NA | Successful target | TTD , DGIDB | Breast[MeSHID:D001940] Neoplasms[MeSHID:D009369] Neoplasm Metastasis[MeSHID:D009362] Malignant neoplasm of breast[MeSHID:D001943] Epidermis[MeSHID:D004817] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.2 | approved | unknown |
| click here to return to the previous page | ||||||||